AGRX — Agile Therapeutics Share News
0.000.00%
Last trade - 00:00- $10.43m
- $7.58m
- $19.59m
Agile Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Agile Therapeutics Announces Delisting From Nasdaq
Agile Therapeutics Inc expected to post a loss of 54 cents a share - Earnings Preview
Brief: Agile Therapeutics Completes Pay-Off Of Debt
U.S. STOCKS ON THE MOVE-Nvidia Corp, Royal Caribbean, Moderna
Brief: Agile Therapeutics- On Dec 5, Got Letter From Nasdaq, Co Granted Additional Period, Until Feb 16, 2024, To Regain Compliance For Continued Listing
Brief: Agile Therapeutics Q3 Net Income USD -799 Thousand
U.S. STOCKS ON THE MOVE-Ford, Energy firms, Natgas firms
Agile Therapeutics soars after Maxim raises rating to 'buy'
Agile Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Agile Therapeutics Inc expected to post a loss of $7.00 a share - Earnings Preview
Brief: Agile Therapeutics Says On June 21, Board Appointed Scott Coiante To Serve As Senior Vice President. CFO And Treasurer, Effective August 16, 2023
Brief: Agile Therapeutics Says Twirla Will Become Available To MMCAP Infuse Members
U.S. STOCKS ON THE MOVE-Netflix, Nova Lifestyle, Nvidia
U.S. STOCKS ON THE MOVE-BlackRock, IPG Photonics, Estee Lauder
U.S. STOCKS ON THE MOVE-Amneal Pharma, 2seventy bio, Blue Water Biotech
U.S. STOCKS ON THE MOVE-Advanced Micro Devices, NextDecade, Agile Therapeutics
Agile Therapeutics gains on agreement to expand access for contraceptive patch
Brief: Agile Therapeutics Announces New Agreement With Vitacare Prescription Services